{
    "Trade/Device Name(s)": [
        "QMS\u00ae Tobramycin"
    ],
    "Submitter Information": "Seradyn, Inc.",
    "510(k) Number": "K060998",
    "Predicate Device Reference 510(k) Number(s)": [
        "K802668"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCR"
    ],
    "Summary Letter Date": "June 29, 2006",
    "Summary Letter Received Date": "June 30, 2006",
    "Submission Date": "June 22, 2006",
    "Regulation Number(s)": [
        "21CFR862.3900"
    ],
    "Regulation Name(s)": [
        "Tobramycin test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology"
    ],
    "Analyte(s)": [
        "Tobramycin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Hitachi 917"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous particle-enhanced turbidimetric immunoassay",
        "Particle agglutination"
    ],
    "Methodologies": [
        "Competitive binding immunoassay",
        "Turbidimetric immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for QMS Tobramycin turbidimetric immunoassay for quantitative measurement of tobramycin in serum or plasma",
    "Indications for Use Summary": "For quantitative determination of tobramycin in human serum or plasma to aid in diagnosis, treatment of overdose, and therapeutic drug monitoring using automated clinical chemistry analyzers",
    "fda_folder": "Toxicology"
}